Machine-learning scoring functions for identifying native poses of ligands docked to known and novel proteins

Ashtawy, Hossam M.; Mahapatra, Nihar R.

doi:10.1186/1471-2105-16-s6-s3

Cited by 47 publications

(37 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such performance discrepancies suggest that it is inappropriate to adopt a scoring function to select poses. As such, pose selections and binding affinity predictions should be carried out independently114115.…”

Section: Discussionmentioning

confidence: 99%

Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme

Leong

Syu

Ding

et al. 2017

Sci Rep

View full text Add to dashboard Cite

The glycine-binding site of the N-methyl-D-aspartate receptor (NMDAR) subunit GluN1 is a potential pharmacological target for neurodegenerative disorders. A novel combinatorial ensemble docking scheme using ligand and protein conformation ensembles and customized support vector machine (SVM)-based models to select the docked pose and to predict the docking score was generated for predicting the NMDAR GluN1-ligand binding affinity. The predicted root mean square deviation (RMSD) values in pose by SVM-Pose models were found to be in good agreement with the observed values (n = 30, r2 = 0.928–0.988, = 0.894–0.954, RMSE = 0.002–0.412, s = 0.001–0.214), and the predicted pKi values by SVM-Score were found to be in good agreement with the observed values for the training samples (n = 24, r2 = 0.967, = 0.899, RMSE = 0.295, s = 0.170) and test samples (n = 13, q2 = 0.894, RMSE = 0.437, s = 0.202). When subjected to various statistical validations, the developed SVM-Pose and SVM-Score models consistently met the most stringent criteria. A mock test asserted the predictivity of this novel docking scheme. Collectively, this accurate novel combinatorial ensemble docking scheme can be used to predict the NMDAR GluN1-ligand binding affinity for facilitating drug discovery.

show abstract

Section: Discussionmentioning

confidence: 99%

Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme

Leong

Syu

Ding

et al. 2017

Sci Rep

View full text Add to dashboard Cite

show abstract

“…There are also some RF‐based SFs optimized from classical empirical SFs by just using the RF to replace the original linear fitting method . For example, SFCscore RF was developed based on the SFCscore descriptors, and it showed significantly better scoring power than SFCscore ( R p = .779 vs. .644), but the LCOCV results indicated that its performance was also highly target‐dependent.…”

Section: Traditional Machine Learning Methods In Scoring Functionsmentioning

confidence: 99%

From machine learning to deep learning: Advances in scoring functions for protein–ligand docking

Shen

Ding

Wang

et al. 2019

WIREs Comput Mol Sci

186

180

View full text Add to dashboard Cite

Molecule docking has been regarded as a routine tool for drug discovery, but its accuracy highly depends on the reliability of scoring functions (SFs). With the rapid development of machine learning (ML) techniques, ML-based SFs have gradually emerged as a promising alternative for protein-ligand binding affinity prediction and virtual screening, and most of them have shown significantly better performance than a wide range of classical SFs. Emergence of more data-hungry deep learning (DL) approaches in recent years further fascinates the exploitation of more accurate SFs. Here, we summarize the progress of traditional ML-based SFs in the last few years and provide insights into recently developed DL-based SFs. We believe that the continuous improvement in ML-based SFs can surely guide the early-stage drug design and accelerate the discovery of new drugs. This article is categorized under:Computer and Information Science > Chemoinformaticsdeep learning, machine learning, molecular docking, scoring function, structure-based drug design | INTRODUCTIONTraditional drug discovery largely relies on the application of high-throughput screening, an experimental technique with acceptable performance but high cost and low efficiency. 1 With the rapid development of computational chemistry and computer technology, computer-aided drug design (CADD) has gradually emerged as a powerful technique in the design and development of new drug candidates in the past three decades. 2 Virtual screening (VS), an important branch of CADD, can enrich potential actives from large virtual compound libraries through in silico methods rather than real experiments, which can not only accelerate the process of drug discovery but also greatly reduce the time and resource cost. 3-5 Depending on whether the three-dimensional (3D) structure of a target is used or not, VS approaches can be classified into two major categories: ligand-based virtual screening (LBVS) and structure-based virtual screening (SBVS). 6 LBVS aims to discover active molecules through the models developed based on a set of known ligands of a target of interest, which may limit its capability to find novel chemotypes. Compared with LBVS, SBVS is considered to be a better choice to discover novel active compounds if the 3D structure of a given target is available. 7 Chao Shen and Junjie Ding are equivalent first authors.

show abstract

“…The second is to introduce a stabilizing factor which draws "dead" nodes away from values close to zero. Both approaches violate the conservation property (7).…”

Section: Clrpmentioning

confidence: 99%

Visualizing convolutional neural network protein-ligand scoring

Hochuli

Helbling

Skaist

et al. 2018

Journal of Molecular Graphics and Modelling

View full text Add to dashboard Cite

Protein-ligand scoring is an important step in a structure-based drug design pipeline. Selecting a correct binding pose and predicting the binding affinity of a protein-ligand complex enables effective virtual screening. Machine learning techniques can make use of the increasing amounts of structural data that are becoming publicly available. Convolutional neural network (CNN) scoring functions in particular have shown promise in pose selection and affinity prediction for protein-ligand complexes. Neural networks are known for being difficult to interpret. Understanding the decisions of a particular network can help tune parameters and training data to maximize performance. Visualization of neural networks helps decompose complex scoring functions into pictures that are more easily parsed by humans. Here we present three methods for visualizing how individual protein-ligand complexes are interpreted by 3D convolutional neural networks. We also present a visualization of the convolutional filters and their weights. We describe how the intuition provided by these visualizations aids in network design.

show abstract

Machine-learning scoring functions for identifying native poses of ligands docked to known and novel proteins

Cited by 47 publications

References 26 publications

Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme

Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme

From machine learning to deep learning: Advances in scoring functions for protein–ligand docking

Visualizing convolutional neural network protein-ligand scoring

Contact Info

Product

Resources

About